U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Izalontamab Brengitecan
INN  
Official Name English
Immunoglobulin G1-scFv_L-kappa dimer, anti-[Homo sapiens EGFR (epidermal growth factor receptor, receptor tyrosine-protein kinase erbB-1, ERBB1, HER1, HER-1, ERBB)] and anti-[Homo sapiens ERBB3 (receptor tyrosine protein kinase erbB-3, HER3)], chimeric a
Common Name English
izalontamab brengitecan [INN]
Common Name English
Fused G1-scFv heavy-lambda heavy chain chimeric and Homo sapiens (1-702) [gamma1 heavy chain anti-EGFR chimeric (1-448) [VH (Mus musculus IGHV2-2*03 (93.8%) -(IGHD) -IGHJ3*01 (92.9%) A128>S (119), CDR-IMGT [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo sap
Common Name English
Code System Code Type Description
INN
12678
Created by admin on Sat Dec 16 19:35:53 GMT 2023 , Edited by admin on Sat Dec 16 19:35:53 GMT 2023
PRIMARY
CAS
2760528-47-8
Created by admin on Sat Dec 16 19:35:53 GMT 2023 , Edited by admin on Sat Dec 16 19:35:53 GMT 2023
PRIMARY
FDA UNII
UC2FX6YY3P
Created by admin on Sat Dec 16 19:35:53 GMT 2023 , Edited by admin on Sat Dec 16 19:35:53 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966